Arka Bagchi
@arkabagchi.bsky.social
L/S Equity, short focused. Scrutinizing low quality companies that are potentially misleading shareholders.
Why is SIGA's market cap is still around $400M? I cannot think of a good reason.
November 28, 2023 at 7:56 PM
Why is SIGA's market cap is still around $400M? I cannot think of a good reason.
Reviva Pharmaceuticals (Ticker: RVPH) has absurd indications for their pipeline. Using an atypical antipsychotic for pulmonary hypertension? Is this a joke?
October 23, 2023 at 3:17 PM
Reviva Pharmaceuticals (Ticker: RVPH) has absurd indications for their pipeline. Using an atypical antipsychotic for pulmonary hypertension? Is this a joke?
The lunatic millionaire Cassava Sciences shareholder who is aggressively defending Wang is losing his mind over the CUNY report and suggesting it was systemic IT failure and committee member bias that threw Wang under the bus. Never mind Wang's inability to produce an iota of an original datum.
October 23, 2023 at 3:09 PM
The lunatic millionaire Cassava Sciences shareholder who is aggressively defending Wang is losing his mind over the CUNY report and suggesting it was systemic IT failure and committee member bias that threw Wang under the bus. Never mind Wang's inability to produce an iota of an original datum.
Cassava Sciences (SAVA) dominoes begin to fall again. Leaked CUNY reports suggest CUNY Committee Responsible for investigating SAVA research misconduct is pissed off at Dr. Wang / SAVA AND the EiC's of these journals that allowed Wang/SAVA to get away with their nonsense.
October 13, 2023 at 2:03 AM
Cassava Sciences (SAVA) dominoes begin to fall again. Leaked CUNY reports suggest CUNY Committee Responsible for investigating SAVA research misconduct is pissed off at Dr. Wang / SAVA AND the EiC's of these journals that allowed Wang/SAVA to get away with their nonsense.
Imo, Axsome Therapeutics (Ticker: AXSM) has considerable downside at this valuation of $3B+ mkt cap. It's shocking the FDA approved their drug that combines DM cough syrup and Wellbutrin without making the company run tox studies, a DM cough syrup monotherapy arm, abuse potential studies, nothing.
October 12, 2023 at 3:53 PM
Imo, Axsome Therapeutics (Ticker: AXSM) has considerable downside at this valuation of $3B+ mkt cap. It's shocking the FDA approved their drug that combines DM cough syrup and Wellbutrin without making the company run tox studies, a DM cough syrup monotherapy arm, abuse potential studies, nothing.
T2 Biosystems (Ticker: TTOO) is one of the most predatory pump and dumps I've seen in a long time in the micro - SMID cap healthcare equities markets, and that is saying quite something. Pumpers crawling all over the web (Twitter, 4chan, stocktwits, reddit). Today shareholders got R/S'd to oblivion.
October 12, 2023 at 3:41 PM
T2 Biosystems (Ticker: TTOO) is one of the most predatory pump and dumps I've seen in a long time in the micro - SMID cap healthcare equities markets, and that is saying quite something. Pumpers crawling all over the web (Twitter, 4chan, stocktwits, reddit). Today shareholders got R/S'd to oblivion.